AiViva BioPharma Press Release May 22, 2023
全球汽車電裝配備大廠輝創電子 5/11興櫃掛牌
兆聯實業(6944)4/27起開始興櫃一般板買賣
創控科技(6909)將於3/30掛牌興櫃交易
益得複方吸入劑在台上市銷售 同步擴大海外布局
Alamar Biosciences Unveils Novel Proteomics Platform with Best-in-Class Capability
The Top 3 Future Foods at CES 2023
Eureka Therapeutics is selected 2022 Red Herring Top 100 Global Winners
〈視陽光學轉上市〉檳城廠持續擴充 明年Q2月產能上看3800萬片增逾2成
Botrista raises $55M, hires former Zoup president to lead strategy
SPAC熱潮再起!+創新T細胞療法公司Estrella上市+估值近4億美元 - 環球生技月刊
永聯物流開發旗下「艾立運能」完成 A 輪募資,布局上中游網路、擴增冷鏈運輸」
Lypid teams up with Louisa Coffee to launch plant based hamburger
BMS acquisition of Turning Point Therapeutics at US$4.1 B closed on 8/15/2022
Applied Biocode is selected top 10 leading molecular diagnostics cos to watch in 2022 by C10 Insight
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
逸達前列腺癌新劑型新藥 CAMCEVI 42 毫克獲加拿大上市許可
Alamar Biosciences Completes $80M Series B Fundraising to Bring UnprecedentedPerformance to the Pro
Turning Point Therapeutics Granted FDA Orphan Drug Designation for TPX-0022 in Gastric Cancer
EUREKA THERAPEUTICS ANNOUNCES INITIATION OF PHASE I/II ARYA-3 CLINICAL TRIAL OF GPC3 TARGETING ARTEM